# FDA Inspection 1010372 - Tedor Pharma, Inc. - April 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/6d50ae4a-31d4-4a0a-a156-4831edc01911
Source feed: FDA_Inspections

> FDA Inspection 1010372 for Tedor Pharma, Inc. on April 20, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010372
- Company Name: Tedor Pharma, Inc.
- Inspection Date: 2017-04-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271887 - 2025-06-05](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/d130b166-4fa4-417a-9823-05222a5913f9)
- [FDA Inspection 1077786 - 2019-01-31](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/84edcb9e-8776-443a-baee-c2e86223d12a)
- [FDA Inspection 853221 - 2013-10-29](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/2a849cad-1259-4b40-9631-e7fdaf65b9c6)
- [FDA Inspection 743987 - 2011-09-09](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/ad54751b-8da0-41ba-802e-221d2e935966)

Company: https://www.keypedia.com/companies/tedor-pharma-inc/a9fa17c4-23c1-4bcf-ad03-bb9635bb063d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c